Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Nov;35(Suppl 2):S187-S190.
doi: 10.5021/ad.21.186.

Drug Reaction with Eosinophilia and Systemic Symptom Syndrome Due to Everolimus: A Case Report

Affiliations
Case Reports

Drug Reaction with Eosinophilia and Systemic Symptom Syndrome Due to Everolimus: A Case Report

Mehmet Erdem Çakmak. Ann Dermatol. 2023 Nov.

Abstract

Drug reaction with eosinophilia and systemic symptom (DRESS) is a life-threatening drug hypersensitivity reaction that is characterized by skin rash, hematological abnormalities (eosinophilia, atypical lymphocytosis), lymphadenopathy, and internal organ involvement (liver, kidneys, and lung). Many drugs may cause DRESS syndrome, the most frequently reported of which are antiepileptics and allopurinol. In this case report, a patient who developed DRESS syndrome due to everolimus was presented herein.

Keywords: Drug hypersensitivity; Eosinophilia; Everolimus; Hypersensitivity.

PubMed Disclaimer

Conflict of interest statement

The author has nothing to disclose.

Figures

Fig. 1
Fig. 1. The patient was admitted to our allergy clinic 10 days after everolimus treatment was discontinued, and the patient’s maculopapular skin rashes had partially resolved.
Fig. 2
Fig. 2. Right lung middle lobe and lower lobe peripheral infiltrations on thorax computed tomography.

References

    1. Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: part I. Clinical perspectives. J Am Acad Dermatol. 2013;68:693.e1–693.e14. quiz 706-708. - PubMed
    1. Muller P, Dubreil P, Mahé A, Lamaury I, Salzer B, Deloumeaux J, et al. Drug hypersensitivity syndrome in a West-Indian population. Eur J Dermatol. 2003;13:478–481. - PubMed
    1. Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, et al. RegiSCAR Study Group. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013;169:1071–1080. - PubMed
    1. James J, Sammour YM, Virata AR, Nordin TA, Dumic I. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome secondary to furosemide: case report and review of literature. Am J Case Rep. 2018;19:163–170. - PMC - PubMed
    1. Cho YT, Yang CW, Chu CY. Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system. Int J Mol Sci. 2017;18:1243. - PMC - PubMed

Publication types